Axa’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $878K | Sell |
1,786
-177
| -9% | -$96.1K | 0.34% | 46 |
|
|
2025
Q4 | $1.14M | Sell |
1,963
-338
| -15% | -$191K | 0.54% | 42 |
|
|
2025
Q3 | $1.12M | Sell |
2,301
-435,426
| -99% | -$203M | 0.56% | 42 |
|
|
2025
Q2 | $177M | Sell |
437,727
-82,824
| -16% | -$34.6M | 0.51% | 35 |
|
|
2025
Q1 | $259M | Sell |
520,551
-127,870
| -20% | -$69.3M | 0.85% | 16 |
|
|
2024
Q4 | $337M | Buy |
648,421
+34,741
| +6% | +$19.1M | 1.02% | 14 |
|
|
2024
Q3 | $380M | Sell |
613,680
-84,897
| -12% | -$50.3M | 1.12% | 12 |
|
|
2024
Q2 | $386M | Buy |
698,577
+93,088
| +15% | +$53.3M | 1.15% | 11 |
|
|
2024
Q1 | $352M | Sell |
605,489
-4,838
| -0.8% | -$2.71M | 1.05% | 14 |
|
|
2023
Q4 | $324M | Sell |
610,327
-45,579
| -7% | -$22.1M | 1.04% | 11 |
|
|
2023
Q3 | $332M | Sell |
655,906
-40,418
| -6% | -$21.5M | 1.17% | 9 |
|
|
2023
Q2 | $363M | Buy |
696,324
+14,334
| +2% | +$7.74M | 1.21% | 10 |
|
|
2023
Q1 | $393M | Sell |
681,990
-32,371
| -5% | -$18.2M | 1.35% | 8 |
|
|
2022
Q4 | $393M | Buy |
714,361
+10,531
| +1% | +$5.58M | 1.42% | 7 |
|
|
2022
Q3 | $357M | Sell |
703,830
-9,804
| -1% | -$5.49M | 1.4% | 8 |
|
|
2022
Q2 | $388M | Sell |
713,634
-16,586
| -2% | -$9.13M | 1.44% | 6 |
|
|
2022
Q1 | $431M | Sell |
730,220
-33,039
| -4% | -$19M | 1.23% | 7 |
|
|
2021
Q4 | $509M | Buy |
763,259
+5,631
| +0.7% | +$3.52M | 1.3% | 6 |
|
|
2021
Q3 | $433M | Sell |
757,628
-17,384
| -2% | -$9.54M | 1.21% | 8 |
|
|
2021
Q2 | $391M | Buy |
775,012
+19,409
| +3% | +$9.16M | 1.1% | 9 |
|
|
2021
Q1 | $345M | Sell |
755,603
-19,442
| -3% | -$9.28M | 1.05% | 9 |
|
|
2020
Q4 | $361M | Buy |
775,045
+15,433
| +2% | +$7.24M | 1.13% | 10 |
|
|
2020
Q3 | $335M | Buy |
759,612
+11,514
| +2% | +$4.76M | 1.21% | 10 |
|
|
2020
Q2 | $271M | Buy |
748,098
+54,601
| +8% | +$18.3M | 1.07% | 10 |
|
|
2020
Q1 | $197M | Sell |
693,497
-71,846
| -9% | -$22.7M | 0.98% | 10 |
|
|
2019
Q4 | $249M | Sell |
765,343
-70,884
| -8% | -$21.5M | 1.01% | 8 |
|
|
2019
Q3 | $244M | Sell |
836,227
-14,710
| -2% | -$4.21M | 0.97% | 8 |
|
|
2019
Q2 | $250M | Sell |
850,937
-7,649
| -0.9% | -$2.11M | 0.98% | 8 |
|
|
2019
Q1 | $235M | Sell |
858,586
-23,830
| -3% | -$5.93M | 0.92% | 9 |
|
|
2018
Q4 | $197M | Sell |
882,416
-22,267
| -2% | -$5.22M | 0.86% | 11 |
|
|
2018
Q3 | $221M | Sell |
904,683
-2,602
| -0.3% | -$599K | 0.81% | 12 |
|
|
2018
Q2 | $188M | Sell |
907,285
-4,525
| -0.5% | -$961K | 0.72% | 18 |
|
|
2018
Q1 | $188M | Buy |
911,810
+12,008
| +1% | +$2.52M | 0.75% | 14 |
|
|
2017
Q4 | $171M | Buy |
899,802
+127,568
| +17% | +$24.4M | 0.67% | 19 |
|
|
2017
Q3 | $146M | Buy |
772,234
+65,083
| +9% | +$11.8M | 0.63% | 26 |
|
|
2017
Q2 | $123M | Buy |
707,151
+75,994
| +12% | +$12.8M | 0.56% | 31 |
|
|
2017
Q1 | $96.9M | Buy |
631,157
+68,557
| +12% | +$10.5M | 0.44% | 48 |
|
|
2016
Q4 | $79.4M | Sell |
562,600
-5,452
| -1% | -$804K | 0.37% | 63 |
|
|
2016
Q3 | $90.4M | Sell |
568,052
-7,226
| -1% | -$1.11M | 0.4% | 62 |
|
|
2016
Q2 | $85M | Sell |
575,278
-166
| -0% | -$24.5K | 0.38% | 61 |
|
|
2016
Q1 | $81.5M | Buy |
575,444
+89,077
| +18% | +$11.9M | 0.37% | 63 |
|
|
2015
Q4 | $69M | Buy |
486,367
+182,837
| +60% | +$24.4M | 0.3% | 90 |
|
|
2015
Q3 | $37.1M | Buy |
303,530
+90,088
| +42% | +$11.7M | 0.15% | 176 |
|
|
2015
Q2 | $27.7M | Sell |
213,442
-30,938
| -13% | -$4.03M | 0.11% | 209 |
|
|
2015
Q1 | $32.8M | Sell |
244,380
-9,102
| -4% | -$1.17M | 0.14% | 185 |
|
|
2014
Q4 | $31.8M | Sell |
253,482
-558,539
| -69% | -$67.9M | 0.13% | 193 |
|
|
2014
Q3 | $98.8M | Sell |
812,021
-153,246
| -16% | -$18.6M | 0.42% | 52 |
|
|
2014
Q2 | $114M | Buy |
965,267
+513,722
| +114% | +$60.5M | 0.47% | 47 |
|
|
2014
Q1 | $54.3M | Sell |
451,545
-4,075
| -0.9% | -$484K | 0.24% | 116 |
|
|
2013
Q4 | $50.7M | Sell |
455,620
-30,827
| -6% | -$3.07M | 0.23% | 129 |
|
|
2013
Q3 | $44.8M | Sell |
486,447
-812,977
| -63% | -$73.5M | 0.22% | 125 |
|
|
2013
Q2 | $110M | Buy |
+1,299,424
| New | +$108M | 0.58% | 34 |
|
Other funds holding TMO
VCM
Axa's TMO Position: Q1 2026 in Review
Axa reduced its Thermo Fisher Scientific (TMO) stake by 9% in Q1 2026, selling an estimated $96.1K and leaving 1,786 shares worth $878K. The position accounts for 0.34% of the portfolio, ranked #46.
Axa first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $509M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Axa held 1,786 shares of Thermo Fisher Scientific worth $878K as of Q1 2026.
- Axa sold 177 Thermo Fisher Scientific shares in Q1 2026, an estimated $96.1K.
- Thermo Fisher Scientific made up 0.34% of Axa's portfolio in Q1 2026, its #46 holding.
- Axa first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Axa's Thermo Fisher Scientific position peaked at $509M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.